Article Text


IL-17 levels in synovium of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis: Target validation in various forms of arthritis
  1. L G M van Baarsen1,
  2. M C Lebre1,
  3. D van der Coelen1,
  4. B C Snoek1,
  5. D M Gerlag1,
  6. P P Tak1
  1. 1Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands


Background Accumulating evidence suggests an important role for interleukin 17 (IL-17) in the pathogenesis of several inflammatory diseases, including rheumatoid arthritis (RA). IL-17A has been well studied in models of arthritis, but little is known about the relative expression of IL-17A, IL-17F, and their receptors in human synovial tissue.

Objective To determine the expression of IL-17A, IL-17F and their receptors IL-17RA and IL-17RC in synovial tissues of patients with RA, psoriatic arthritis (PsA) and osteoarthritis (OA).

Methods Synovial biopsy specimens were obtained by arthroscopy from patients with RA (n=13), PsA (n=15) and inflammatory OA (n=14). For comparison synovial tissues from non-inflammatory controls (n=7) were included. Immunohistological analysis was performed using monoclonal antibodies specific for IL-17A, IL-17F, IL-17RA and IL-17RC. Stained sections were evaluated by digital image analysis.

Results Levels of IL-17A, IL-17F, IL-17RA and IL-17RC were abundantly present in synovial tissues of all patient groups and highly variable between patients. Digital image analysis showed a significant increase of IL-17A and IL-17RC, but not of IL-17F and IL-17RA in patients with arthritis compared to non-inflamed control tissues, while the expression of IL-17A, IL-17F and IL-17RA was similar between the different patient groups. Expression of IL-17RC in the synovial lining was significantly increased in PsA compared to OA patients.

Conclusions Increased expression of IL-17A is not restricted to synovial tissues of RA patients but also observed in other forms of inflammatory arthritis. In contrast, the expression of IL-17F is not significantly increased. IL-17A blockade could provide a novel therapeutic approach in a variety of arthritides.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.